Effect of PON1 Q192R genetic polymorphism on clopidogrel efficacy and cardiovascular events in the Clopidogrel in the Unstable Angina to Prevent Recurrent Events trial and the Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events.
Paré, Guillaume
Effect of PON1 Q192R genetic polymorphism on clopidogrel efficacy and cardiovascular events in the Clopidogrel in the Unstable Angina to Prevent Recurrent Events trial and the Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events. [electronic resource] - Circulation. Cardiovascular genetics Apr 2012 - 250-6 p. digital
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, Non-P.H.S.
1942-3268
10.1161/CIRCGENETICS.111.961417 doi
Adult
Aged
Angina, Unstable--complications
Aryldialkylphosphatase--genetics
Atrial Fibrillation--drug therapy
Clopidogrel
Female
Humans
Male
Middle Aged
Polymorphism, Single Nucleotide
Risk Factors
Ticlopidine--analogs & derivatives
Effect of PON1 Q192R genetic polymorphism on clopidogrel efficacy and cardiovascular events in the Clopidogrel in the Unstable Angina to Prevent Recurrent Events trial and the Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events. [electronic resource] - Circulation. Cardiovascular genetics Apr 2012 - 250-6 p. digital
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, Non-P.H.S.
1942-3268
10.1161/CIRCGENETICS.111.961417 doi
Adult
Aged
Angina, Unstable--complications
Aryldialkylphosphatase--genetics
Atrial Fibrillation--drug therapy
Clopidogrel
Female
Humans
Male
Middle Aged
Polymorphism, Single Nucleotide
Risk Factors
Ticlopidine--analogs & derivatives